BALDOVINO, Simone
 Distribuzione geografica
Continente #
NA - Nord America 8.744
EU - Europa 5.859
AS - Asia 3.858
SA - Sud America 919
AF - Africa 145
OC - Oceania 99
Continente sconosciuto - Info sul continente non disponibili 22
Totale 19.646
Nazione #
US - Stati Uniti d'America 8.237
IT - Italia 1.874
CN - Cina 1.421
SG - Singapore 680
DE - Germania 596
FR - Francia 485
IE - Irlanda 409
JP - Giappone 408
ES - Italia 395
BR - Brasile 369
GB - Regno Unito 351
MX - Messico 312
SE - Svezia 298
FI - Finlandia 252
IN - India 229
UA - Ucraina 209
CO - Colombia 207
KR - Corea 191
CA - Canada 157
VN - Vietnam 152
TR - Turchia 149
PL - Polonia 134
ID - Indonesia 125
AT - Austria 113
AR - Argentina 102
RU - Federazione Russa 95
GR - Grecia 94
NL - Olanda 94
AU - Australia 88
CH - Svizzera 84
HK - Hong Kong 80
PT - Portogallo 78
CL - Cile 74
TW - Taiwan 74
SA - Arabia Saudita 64
PE - Perù 59
RO - Romania 56
BE - Belgio 55
EC - Ecuador 49
IR - Iran 47
TH - Thailandia 47
IL - Israele 45
EG - Egitto 38
VE - Venezuela 37
SI - Slovenia 29
CZ - Repubblica Ceca 26
PK - Pakistan 24
RS - Serbia 23
EU - Europa 21
NO - Norvegia 19
TN - Tunisia 19
ZA - Sudafrica 19
PH - Filippine 18
DZ - Algeria 17
AE - Emirati Arabi Uniti 16
PS - Palestinian Territory 15
HU - Ungheria 14
LT - Lituania 13
NG - Nigeria 13
UZ - Uzbekistan 13
DK - Danimarca 12
HR - Croazia 12
MY - Malesia 12
BG - Bulgaria 11
NZ - Nuova Zelanda 11
MA - Marocco 10
UY - Uruguay 10
BO - Bolivia 8
CR - Costa Rica 8
IQ - Iraq 8
GT - Guatemala 7
NI - Nicaragua 7
LB - Libano 6
BD - Bangladesh 5
BY - Bielorussia 5
JO - Giordania 5
KE - Kenya 5
LK - Sri Lanka 5
PA - Panama 5
QA - Qatar 5
EE - Estonia 4
GH - Ghana 4
MK - Macedonia 4
MT - Malta 4
NP - Nepal 4
PY - Paraguay 4
RE - Reunion 4
SK - Slovacchia (Repubblica Slovacca) 4
CM - Camerun 3
CU - Cuba 3
LI - Liechtenstein 3
SV - El Salvador 3
UG - Uganda 3
AN - Antille olandesi 2
AZ - Azerbaigian 2
BN - Brunei Darussalam 2
IS - Islanda 2
MM - Myanmar 2
NE - Niger 2
TG - Togo 2
Totale 19.630
Città #
Ann Arbor 902
Santa Clara 622
Chandler 543
Beijing 531
Fairfield 501
Dublin 389
Singapore 383
Redwood City 380
Houston 362
Torino 361
Wilmington 333
Ashburn 265
Woodbridge 239
Seattle 212
Villeurbanne 173
Cambridge 161
Turin 155
Jacksonville 148
Medford 136
Princeton 132
Pisa 121
Milan 120
Dearborn 108
Munich 107
Columbus 106
Nyköping 101
Tokyo 101
Warsaw 98
Guangzhou 97
Shanghai 92
Helsinki 85
Lubbock 83
Dong Ket 77
Vienna 77
Bogotá 67
Fremont 66
Jakarta 65
Nanjing 65
Madrid 62
São Paulo 61
Boston 55
Rome 54
Hangzhou 53
Santiago 53
Medellín 50
San Diego 49
Hong Kong 46
Barcelona 43
London 42
New York 42
Mexico City 41
Buenos Aires 40
Paris 40
Lima 37
Los Angeles 37
Seoul 35
Chengdu 34
Toronto 34
Taipei 33
Guadalajara 30
Istanbul 29
Silver Spring 29
Athens 28
Chicago 28
Osaka 28
Mumbai 26
Wuhan 26
Düsseldorf 25
Mexico 24
Zapopan 24
Zhengzhou 24
Ankara 23
Belo Horizonte 23
Changsha 23
Nuremberg 23
Sesto San Giovanni 23
Brussels 22
Hefei 22
Norwalk 22
Ottawa 22
Padova 22
Jinan 21
Lisbon 20
Buffalo 19
Cuauhtémoc 19
Hanoi 19
Quito 19
Gurgaon 18
Lissone 18
New Delhi 18
Phoenix 18
Riyadh 18
Rochester 18
Berlin 17
Boardman 17
Caracas 17
Kunming 17
Munro 17
Montreal 16
Zurich 16
Totale 10.393
Nome #
Chronic kidney disease and anticoagulation: from vitamin K antagonists and heparins to direct oral anticoagulant agents 1.088
Acute kidney injury associated with glomerular diseases 1.063
Antiphospholipid Syndrome and the Kidney 912
Value of colchicine as treatment for recurrent oral ulcers: a systematic review 638
Central nervous system involvement in systemic lupus erythematosus: Overview on classification criteria. 601
Common variable immunodeficiency: Crossroads between infections, inflammation and autoimmunity. 545
The adjusted Global AntiphosPholipid Syndrome Score (aGAPSS) for risk stratification in young APS patients with acute myocardial infarction 543
Improved (4 Plus 2) rituximab protocol for severe cases of mixed cryoglobulinemia: A 6-year observational study 540
Long-term effects of methylprednisolone pulses and mycophenolate mofetil in IgA nephropathy patients at risk of progression. 505
A 4-year observation in lupus nephritis patients treated with an intensified B-lymphocyte depletion without immunosuppressive maintenance treatment-Clinical response compared to literature and immunological re-assessment 483
Long-term effects of rituximab added to cyclophosphamide in refractory patients with vasculitis. 477
High-Dose Rituximab Ineffective for Focal Segmental Glomerulosclerosis: A Long-Term Observation Study 448
Retreatment regimen of rituximab monotherapy given at the relapse of severe HCV-related cryoglobulinemic vasculitis: Long-term follow up data of a randomized controlled multicentre study 427
Intensive short-term treatment with rituximab, cyclophosphamide and methylprednisolone pulses induces remission in severe cases of SLE with nephritis and avoids further immunosuppressive maintenance therapy 387
Mycophenolate mofetil as steroid-sparing treatment for elderly patients with giant cell arteritis: report of three cases. 345
The role of nail-videocapillaroscopy in early diagnosis of scleroderma 311
Evaluation of novel assays for the detection of autoantibodies in antiphospholipid syndrome 307
Upcoming biological therapies in systemic lupus erythematosus. 295
Antiphospholipid syndrome in northwest Italy (APS Piedmont Cohort): demographic features, risk factors, clinical and laboratory profile. 290
8-Isoprostane, prostaglandin E2, C-reactive protein and serum amyloid A as markers of inflammation and oxidative stress in antiphospholipid syndrome: a pilot study. 282
Long-term evaluation of pemphigus vulgaris: a retrospective consideration of 98 patients treated in an oral medicine unit in North-West Italy 259
Use of intravenous immunoglobulin in patients with active vasculitis associated with concomitant infection 245
Systemic AA amyloidosis as a unique manifestation of a combined mutation of TNFRSF1A and MEFV genes. 225
Rituximab in cryoglobulinemic peripheral neuropathy 222
A 4 Plus 2 Infusion Protocol of Rituximab Provides Long-Term Beneficial Effects in Patients with HCV-Associated Mixed Cryoglobulinemia with Membranoproliferative Nephritis and Severe Polyneuropathy. 218
Outcome of patients with severe AL amyloidosis and biopsy-proven renal involvement ineligible for bone marrow transplantation 213
Antiphospholipid syndrome and relapsing polychondritis: an unusual association. 203
The challenge of treating hepatitis C virus-associated cryoglobulinemic vasculitis in the era of anti-CD20 monoclonal antibodies and direct antiviral agents 196
The prompt use of rituximab could decrease adverse effects in patient with pemphigus vulgaris: a preliminary evaluation 196
Biallelic variants in the ciliary gene TMEM67 cause RHYNS syndrome 189
L'importanza del laboratorio nella diagnosi e nella gestione della porpora trombotica trombocitopenica 188
Outpatient percutaneous native renal biopsy: Safety profile in a large monocentric cohort 186
Clinical exome sequencing is a powerful tool in the diagnostic flow of monogenic kidney diseases: an Italian experience 183
The "4 plus 2" rituximab protocol makes maintenance treatment unneeded in patients with refractory ANCA-associated vasculitis: A 10 years observation study 182
The case of SLE associated Sneddon-Wilkinson pustular disease successfully and safely treated with infliximab 179
Chiari and Syringomyelia Consortium: a model of multidisciplinary and sharing path for rare diseases. 170
Thrombotic risk assessment in antiphospholipid syndrome: The role of new antibody specificities and thrombin generation assay 170
Reliability of lupus anticoagulant and anti-phosphatidylserine/prothrombin autoantibodies in antiphospholipid syndrome: A multicenter study 161
Facilitated subcutaneous immunoglobulin treatment in pemphigus vulgaris 148
Daratumumab Monotherapy in Severe Patients with AL Amyloidosis and Biopsy-Proven Renal Involvement: A Real Life Experience 145
Filling the gap in antiphospholipid syndrome diagnosis: a patient's story 140
CD38 and anti-CD38 monoclonal antibodies in AL amyloidosis: Targeting plasma cells and beyond 140
Long-term effects of anti-CD20 monoclonal antibody treatment of cryoglobulinaemic glomerulonephritis 138
Short and long-term effects of Rituximab in the treatment of severe cryoglobulinaemia with and without glomerulonephritis 129
Extemporaneous orphan drugs and preparations for rare diseases: organisation and management of an inter-regional network 128
External Quality Assurance (EQA) of Immunofixation and serum free light chain measure in 9 laboratories participating in the Piedmont and Aosta Valley consortium for systemic amyloidosis 126
First considerations on the SARS-CoV-2 epidemic in the Dialysis Units of Piedmont and Aosta Valley, Northern Italy 125
USE OF CLINICAL EXOME SEQUENCING IN THE DIAGNOSTIC FLOW OF MONOGENIC KIDNEY DISEASES: THE PIEDMONT EXPERIENCE 125
null 122
NOVEL AND KNOWN MUTATIONS IDENTIFIED BY CLINICAL EXOME SEQUENCING FOR THE DIAGNOSIS OF POLYCYSTIC KIDNEY DISEASE 117
Analisi di Copy-Number Variants (CNV) e dei polimorfismi del gene C4 nelle vasculiti primitive e secondarie e nell’ artrite reumatoide. 116
Tailoring tofacitinib oral therapy in rheumatoid arthritis: The TuTORApp—a usability study 114
Anti-beta-2-glycoprotein I domain 1 identifies antiphospholipid antibodies-related injuries in patients with concomitant lupus nephritis 103
Anticorpo monoclonale anti CD 20 come opzione terapeutica in quadri severi di Lupus Eritematoso Sistemico 102
C1 esterase inhibitor deficiency and SLE: A case report and review of the literature 99
Efficacy of low or standard rituximab-based protocols and comparison to Ponticelli’s regimen in membranous nephropathy 99
Identifying phenotypes of patients with antiphospholipid antibodies: results from a cluster analysis in a large cohort of patients 98
Immunological rare diseases 98
Effetti a lungo termine del rituximab nel trattamento delle forme più severe di crioglobulinemia mista HCV associata 97
Safety of outpatient percutaneous native renal biopsy in systemic autoimmune diseases: results from a monocentric cohort 96
Antiphospholipid Syndrome Is Still a Rare Disease—Estimated Prevalence in the Piedmont and Aosta Valley Regions of Northwest Italy: Comment on the Article by Duarte-García et al 96
Syringomyelia and Chiari Syndrome Registry: advances in epidemiology, clinical phenotypes and natural history based on a North Western Italy cohort 94
OC9 Successful use of mycophenolate mofetil in combination with minocycline in a woman with severe predominantly oral mucous membrane pemphigoid: a case report 93
Anticorpo monoclonale anti CD20 nella crioglobulinemia mista 92
New insights into immune mechanisms underlying response to Rituximab in patients with membranous nephropathy: A prospective study and a review of the literature 88
Immunotherapies in phase II and III trials for the treatment of systemic lupus erythematosus 88
OC9 Successful use of mycophenolate mofetil in combination with minocycline in a woman with severe predominantly oral mucous membrane pemphigoid: a case report 87
Association between hereditary angioedema and lupus erythematosus in the mother and the son 81
Induction of remission by B lymphocyte depletion in patients with idiopathic systemic vasculitis 79
Towards a novel target therapy for renal diseases related to plasma cell dyscrasias: The example of AL amyloidosis 79
Anti-neuronal antibodies in patients with HCV-related mixed cryoglobulinemia 78
EFFECTS OF RITUXIMAB IN THE TREATMENT OF SEVERE CRYOGLOBULINAEMIA 78
Percorso gestionale standardizzato dalla prescrizione all'erogazione di galenici magistrali per pazienti affetti da malattie rare ed allestiti presso le farmacie ospedaliere di Piemonte e Valle d'Aosta 77
Cryoglobulinemic glomerulonephritis: Clinical presentation and histological features, diagnostic pitfalls and controversies in the management. State of the art and the experience on a large monocentric cohort treated with B cell depletion therapy 76
Anticorpo monoclonale anti CD 20 come opzione terapeutica in quadri severi di Lupus Eritematoso sistemico 75
Short and long term effects on Rituximab in the treatment of severe cryoglubulinaemia with and without glomerulonephritis 75
Terapia di induzione della remissione nelle vasculiti primitive sistemiche mediante deplezione linfocitaria B 74
INTENSIFIED B LYMPHOCYTE DEPLETION (IBLD) WITHOUT IMMUNOSUPPRESSIVE MAINTENANCE TREATMENT AS A RESCUE THERAPY IN REFRACTORY LUPUS NEPHRITIS (LN): A 4-YEAR OBSERVATION 74
Immunogenetics of complement in mixed cryoglobulinaemia 73
Renal Involvement in Transthyretin Amyloidosis: The Double Presentation of Transthyretin Amyloidosis Deposition Disease 70
Alterazioni videocapillaroscopiche nella crioglobulinemia mista ocn danno renale 68
Induction of remission by B lynfocyte depletion in patients with idiopathic systemic vasculitis 67
Piedmont and Aosta Valley inter-regional network in the context of the Italian National Network for rare diseases. 67
Piedmont and Aosta Valley Consortium of Systemic Amyloidosis: results of a four year experience 66
Intensified Treatment of B Lymphocyte Depletion (ITBLD) without Immunosuppressive Maintenance Treatment As a Rescue Therapy in Refractory Lupus Nephritis (LN): A 4-Year Observation 66
Improving diagnosis for rare diseases: The experience of the Italian undiagnosed Rare diseases network 63
Safety and tolerability of mRNA COVID-19 vaccines in people with antiphospholipid antibodies 63
Malattie Rare: la rete di segnalazione 61
La crioglobulinemia mista 59
Relationship between cryoglobulinemia-associated nephritis and HCV infection 59
Purificazione e caratterizzazione di proteasomi renali umani 58
Rare diseases in Europe: From a wide to a local perspective 58
Nail fold capillaroscopy in mixed cryoglobulinaemia 57
Terapia di induzione della remissione nelle vasculiti primitive sistemiche mediante deplezione linfocitaria B 57
Structural and functional properties of proteasomes purified from the human kidney 56
Minocycline in combination with mycophenolate mofetil in oral mucous membrane pemphigoid 56
Orofacial granulomatosis’ features in a patient with a common variable immunodeficiency. 55
Vedolizumab for the Management of Refractory Behçet’s Disease: From a Case Report to New Pieces of Mosaic in a Complex Disease 55
Rituximab as a Therapeutic Tool in Severe Mixed Cryoglobulinemia 54
VERY LONG-TERM Effects Of The "4 PLUS2 Infusion PROTOCOL" Of Rituximabalone In Patients With HCV-Associatedmixed Cryoglobulinemia With Diffusemembranoproliferative Glomerulonephritis, Severe Polyneuropathy and Necrotic Ulcersof Skin 53
Totale 19.502
Categoria #
all - tutte 47.333
article - articoli 0
book - libri 0
conference - conferenze 7.942
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.275


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020322 0 0 0 0 0 0 0 0 0 0 163 159
2020/20212.400 176 153 218 116 245 197 162 173 214 239 220 287
2021/20223.033 153 163 201 295 321 286 326 273 221 178 277 339
2022/20232.496 252 194 89 175 177 524 205 221 257 113 165 124
2023/20241.791 230 224 141 134 178 132 127 114 41 134 132 204
2024/20253.046 88 206 211 309 815 291 201 239 402 223 61 0
Totale 20.270